151 related articles for article (PubMed ID: 19030751)
1. Impact of extended lymphadenectomy on morbidity, mortality, recurrence and 5-year survival after gastrectomy for cancer. Meta-analysis of randomized clinical trials.
Lustosa SA; Saconato H; Atallah AN; Lopes Filho Gde J; Matos D
Acta Cir Bras; 2008; 23(6):520-30. PubMed ID: 19030751
[TBL] [Abstract][Full Text] [Related]
2. Extent of lymph node dissection for adenocarcinoma of the stomach.
Mocellin S; McCulloch P; Kazi H; Gama-Rodrigues JJ; Yuan Y; Nitti D
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD001964. PubMed ID: 26267122
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of D1 versus D2 gastrectomy for gastric adenocarcinoma.
Memon MA; Subramanya MS; Khan S; Hossain MB; Osland E; Memon B
Ann Surg; 2011 May; 253(5):900-11. PubMed ID: 21394009
[TBL] [Abstract][Full Text] [Related]
4. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues JJ
Cochrane Database Syst Rev; 2012 Jan; 1():CD001964. PubMed ID: 22258947
[TBL] [Abstract][Full Text] [Related]
6. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues J
Cochrane Database Syst Rev; 2004 Oct; (4):CD001964. PubMed ID: 15495024
[TBL] [Abstract][Full Text] [Related]
7. Extended versus limited lymph nodes dissection technique for adenocarcinoma of the stomach.
McCulloch P; Nita ME; Kazi H; Gama-Rodrigues J
Cochrane Database Syst Rev; 2003; (4):CD001964. PubMed ID: 14583942
[TBL] [Abstract][Full Text] [Related]
8. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
[TBL] [Abstract][Full Text] [Related]
9. Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer.
McCulloch P; Niita ME; Kazi H; Gama-Rodrigues JJ
Br J Surg; 2005 Jan; 92(1):5-13. PubMed ID: 15635680
[TBL] [Abstract][Full Text] [Related]
10. [Total gastrectomy for gastric cancer: can the type of lymphadenectomy condition the long-term results?].
Di Martino N; Izzo G; Cosenza A; Vicenzo L; Monaco L; Torelli F; Basciotti A; Brillantino A; Marra A
Suppl Tumori; 2005; 4(3):S84-5. PubMed ID: 16437920
[TBL] [Abstract][Full Text] [Related]
11. In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection-D1 Versus D2 Versus D3?
Mogal H; Fields R; Maithel SK; Votanopoulos K
Ann Surg Oncol; 2019 Sep; 26(9):2912-2932. PubMed ID: 31076930
[TBL] [Abstract][Full Text] [Related]
12. Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials.
Mocellin S; Nitti D
Cancer Treat Rev; 2015 May; 41(5):448-54. PubMed ID: 25814393
[TBL] [Abstract][Full Text] [Related]
13. Randomized clinical trial comparing survival after D1 or D2 gastrectomy for gastric cancer.
Degiuli M; Sasako M; Ponti A; Vendrame A; Tomatis M; Mazza C; Borasi A; Capussotti L; Fronda G; Morino M;
Br J Surg; 2014 Jan; 101(2):23-31. PubMed ID: 24375296
[TBL] [Abstract][Full Text] [Related]
14. [Distal subtotal gastrectomy and gastreectomy in surgical treatment of patients with gastric cancer: a systematic review and meta-analysis].
Panin SI; Postolov MP; Kovalenko NV; Beburishvili AG; Fedorov AV; Bykov AV
Khirurgiia (Mosk); 2020; (11):93-100. PubMed ID: 33210514
[TBL] [Abstract][Full Text] [Related]
15. Resection for gastric cancer in the community.
van de Velde CJ
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S90-3. PubMed ID: 16399441
[TBL] [Abstract][Full Text] [Related]
16. Is D2 lymphadenectomy in gastrectomy safe with regard to the skill of the operator?
Moriwaki Y; Kobayashi S; Kunisaki C; Harada H; Imai S; Kido Y; Kasaoka C
Dig Surg; 2001; 18(2):111-7. PubMed ID: 11351155
[TBL] [Abstract][Full Text] [Related]
17. Does D3 surgery offer a better survival outcome compared to D1 surgery for gastric cancer? A result based on a hospital population of two decades as taking D2 surgery for reference.
Zhang H; Liu C; Wu D; Meng Y; Song R; Lu P; Wang S
BMC Cancer; 2010 Jun; 10():308. PubMed ID: 20565910
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic vs open D2 gastrectomy for locally advanced gastric cancer: a meta-analysis.
Zou ZH; Zhao LY; Mou TY; Hu YF; Yu J; Liu H; Chen H; Wu JM; An SL; Li GX
World J Gastroenterol; 2014 Nov; 20(44):16750-64. PubMed ID: 25469048
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
[TBL] [Abstract][Full Text] [Related]
20. Survival and recurrence free benefits with different lymphadenectomy for resectable gastric cancer: a meta-analysis.
Jiang L; Yang KH; Guan QL; Zhao P; Chen Y; Tian JH
J Surg Oncol; 2013 Jun; 107(8):807-14. PubMed ID: 23512524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]